Product Information
LORAZEPAM 2 MG/ML ORAL CONCENT is a generic product labeled by Chartwell RX LLC, priced at $0.6928 per ML under NDC 62135054943. Its NADAC has been published 108 times since Jul 31, 2024.
FDA first approved this application on Apr 28, 2009.
Strength
2 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135054943
Classification
Generic
Dosage Form
CONCENTRATE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA079244FDA Approved
4/28/2009
On Market Since
4/28/2009
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has been published 108 times since Jul 31, 2024, and over the history we have for it it has risen 28.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6928 per ML |
|---|---|
| All-time high | $0.6928 (Aug 19, 2026) |
| All-time low | $0.5405 (Jul 31, 2024) |
| 52-week high | $0.6928 |
| 52-week low | $0.6128 |
| Median price | $0.6326 |
| Average price | $0.6230 |
| Largest weekly change | +13.6% (Aug 21, 2024) |
| Weeks tracked | 108 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG/ML ORAL CONCENT?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML ORAL CONCENT, manufactured by Chartwell RX LLC, is $0.6928 per ML (NDC 62135054943), effective Aug 19, 2026.
How has the price of LORAZEPAM 2 MG/ML ORAL CONCENT changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has risen 28.2%. It has been tracked across 108 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML ORAL CONCENT?
Since Jul 31, 2024, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has ranged from a low of $0.5405 (Jul 31, 2024) to a high of $0.6928 (Aug 19, 2026), with a median of $0.6326 per ML.
Are there cheaper alternatives to LORAZEPAM 2 MG/ML ORAL CONCENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 2 MG/ML ORAL CONCENT in a comparable dosage form, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG/ML ORAL CONCENT?
LORAZEPAM 2 MG/ML ORAL CONCENT (NDC 62135054943) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.